Influence of FSH/LH Ratio in Controlled Ovarian Stimulation

The aim of this study is to compare different FSH/LH ratios in controlled ovarian stimulation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sub-Fertility Genital Diseases Infertility Urogenital Diseases

Age range

35 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Early Phase 1

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients undergoing IVF cycles in Cruces University Hospital.
Signed IVF and cryopreservation informed consent.
Age >35 and <40 years.
FSH levels <10 mIU/ml.

Exclusion criteria

When inclusion criteria are not fulfilled

Treatment and study plan

FSH/LH

Drug

Primary outcomes

Pregnancy achievement

Time frame: 3 months after drug administration

To report our results in terms of pregnancy per embryo transfer

Sponsors and collaborators

Lead sponsor

Hospital de Cruces

Other

Registry information

Official study title

Influence of FSH/LH Ratio in Controlled Ovarian Stimulation ( 2/1 Ratio vs 4/1 Ratio) in >35 Years Women Undergoing IVF

Important dates

Study start: 2017
Primary completion: 2017
Study completion: 2018
First posted: Dec 16, 2016
Registry last updated: Aug 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed